Chr. Hansen Holding

Less than 1K followers

All

Press releases

ShowingAll content types

Regulatory press release1/29/2024, 10:26 AM

Completion of the combination between Novozymes and Chr. Hansen

Chr. Hansen Holding

Regulatory press release1/26/2024, 11:09 AM

All necessary regulatory approvals have been obtained for the combination of Novozymes and Chr. Hansen

Chr. Hansen Holding

Press release12/20/2023, 2:02 PM

Update on the merger approval process for the combination of Novozymes and Chr. Hansen: South Korean merger approval granted

Chr. Hansen Holding

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account

Followings and notifications on followed companies

Analyst comments and recommendations

Stock comparison tool & other popular tools

Regulatory press release12/19/2023, 10:54 AM

Major shareholder announcement from Burlington Loan Management DAC

Chr. Hansen Holding

Press release12/12/2023, 4:11 PM

Update on the merger approval process for the combination of Novozymes and Chr. Hansen: Conditional competition clearance from the European Commission obtained

Chr. Hansen Holding

Regulatory press release11/20/2023, 7:03 AM

Update on the merger approval process for the combination of Novozymes and Chr. Hansen: The parties have submitted a remedy proposal to the European Commission.

Chr. Hansen Holding

Regulatory press release11/2/2023, 12:10 PM

Managers' Transaction

Chr. Hansen Holding

Regulatory press release10/13/2023, 1:15 PM

Managers' Transactions

Chr. Hansen Holding

Regulatory press release10/12/2023, 6:02 AM

Chr. Hansen Holding A/S Interim Report Q4 2022/23

Chr. Hansen Holding

Regulatory press release10/10/2023, 6:08 AM

Novozymes announce the Executive Leadership Team and organizational structure for the future combined company of Novozymes and Chr. Hansen

Chr. Hansen Holding

Regulatory press release9/27/2023, 7:23 AM

Major shareholder announcements from Burlington Loan Management DAC and Davidson Kempner Capital Management LP

Chr. Hansen Holding

Regulatory press release9/4/2023, 9:48 AM

Update on the combination of Novozymes and Chr. Hansen: Chinese merger approval granted, supporting the path to completion

Chr. Hansen Holding

Regulatory press release7/6/2023, 6:03 AM

Chr. Hansen Holding A/S Interim Report Q3 2022/23

Chr. Hansen Holding

Regulatory press release4/13/2023, 6:02 AM

Chr. Hansen Holding A/S Interim Report Q2 2022/23

Chr. Hansen Holding

Regulatory press release3/30/2023, 4:07 PM

Novozymes’ and Chr. Hansen’s shareholders approve combination to create a leading global biosolutions partner

Chr. Hansen Holding

Regulatory press release3/30/2023, 3:57 PM

Resolutions passed at the Extraordinary General Meeting of Chr. Hansen Holding A/S

Chr. Hansen Holding

Regulatory press release3/30/2023, 11:11 AM

Combination between Novozymes and Chr. Hansen approved by Novozymes’ shareholders

Chr. Hansen Holding

Regulatory press release3/28/2023, 10:07 AM

Update on the combination of Novozymes and Chr. Hansen: U.S. antitrust regulation waiting period has expired, supporting the path to completion

Chr. Hansen Holding

Regulatory press release3/8/2023, 7:05 AM

Notice to convene Extraordinary General Meeting

Chr. Hansen Holding

Regulatory press release3/8/2023, 7:00 AM

Publication of exemption document in relation to the proposed combination of Chr. Hansen and Novozymes, confirmation of outlook for 2022/23 and proposed candidates to the Board of Directors of the combined company

Chr. Hansen Holding

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.